Nile Pharmaceuticals

مادة اعلانية

Latest Update: 22 Dec 2024 16:25 Abu Dhabi Time.

Market Status: Closed

NIPH

Nile Pharmaceuticals

54.83

EGP

-1.000

-1.79%

Open

55.83

Prev Close

55.83

PX_VOLUME

47,978

MARKET CAP (M)

DAY RANGE

54.75 - 56.90

52 WEEKS

25.86 - 75.30

Stock Statistics

Yearly Change

65.85%

Listed Shares (Million)

30.00

Earnings Multiple

57.65

Average 30-day trading volume

Price-to-book ratio

3.11

Earnings Per Share

3.55

Previous Dividend Distribution

Dividend Yield

3.56%

Financial Summary

Quarterly
Annual

Income Statements

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023
Total Revenue		121.77	79.23	296.69	387.93	378.73
Gross Profit		34.81	-22.98	66.54	99.51	109.37
Operating Income		12.05	-45.43	42.77	64.98	81.19
Profit Margin		-9.64	-40.59	8.89	10.87	14.22

	Period Ending:	Jun 30, 2024	Jun 30, 2023
Total Revenue	1,142.58	1,005.22
Gross Profit	252.43	271.81
Operating Income	143.52	162.76
Profit Margin	7.90	11.86

Balance Sheet

	Period Ending:	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023
Total Assets		1,568.73	1,473.19	1,420.28	1,201.86	1,106.13	1,038.29
Total Liabilities		1,111.61	1,004.34	905.13	710.54	573.80	559.81
Total Equity		457.12	468.86	515.14	491.33	532.32	478.48

	Period Ending:	Jun 30, 2024	Jun 30, 2023
Total Assets	1,473.19	1,038.29
Total Liabilities	1,004.34	559.81
Total Equity	468.86	478.48

Cash Flows Statements - Coming Soon

* In Million of Egypt Pound

Reminder: The financial information on this website is delayed information that are originates from certified data providers in the financial markets, who retain the rights and intellectual property of this data, absolving ADMN of any responsibility.